India Porcine Vaccines Market Research Report By Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine influenza, Aujeszky's disease (AD), Porcine Circovirus Associated Disease (PCVAD), Others) and By End-user (Veterinary Hospitals, Hog Production Farm)- Forecast to 2035

India Porcine Vaccines Market Overview

As per MRFR analysis, the India Porcine Vaccines Market Size was estimated at 89.5 (USD Million) in 2024. The India Porcine Vaccines Market Industry is expected to grow from 96 (USD Million) in 2025 to 213 (USD Million) by 2035. The India Porcine Vaccines Market CAGR (growth rate) is expected to be around 7.514% during the forecast period (2025 - 2035).

The India Porcine Vaccines Market is significantly influenced by a rise in pig farming activities and the increasing consumption of pork among the Indian population. This growing interest in livestock health management is driven by both the need for quality meat products and the rising awareness of animal welfare.

The government of India has been implementing measures to promote biosecurity and vaccination programs among farmers, which bolsters the importance of porcine vaccines in disease prevention. Partnerships between agricultural departments and veterinary practitioners are also becoming more common, enhancing the distribution and accessibility of vaccines in rural areas.

Opportunities in the market are emerging as demand for efficient and effective vaccines increases. Innovations in vaccine formulations are being explored, which can improve immunity and reduce the incidence of diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS) and swine influenza.

The growing trend toward sustainable farming practices presents an additional avenue as farmers seek eco-friendly vaccine options that align with modern agricultural practices. Recent trends indicate a shift towards integrating technology in livestock management, including the use of digital platforms for disease tracking and vaccination records.

This technological advancement is affecting how veterinarians and farmers interact, making it easier to monitor pig health. Additionally, there is a rising trend of collaborative efforts among industry stakeholders to address challenges in vaccine distribution logistics, ensuring that vaccines reach farms timely and efficient. Overall, the India Porcine Vaccines Market is evolving with a strong emphasis on health management, technological integration, and sustainable farming practices, positioning itself for future growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Porcine Vaccines Market Drivers

Increasing Awareness of Animal Health

There is a growing awareness among pig farmers in India regarding the importance of vaccination in controlling diseases and enhancing productivity. According to the Animal Husbandry Department of the Government of India, there has been a notable increase in vaccination coverage among livestock, with approximately 75% of farmers now vaccinating their animals.

This is largely driven by initiatives from organizations such as the Indian Veterinary Association that advocate for disease prevention through preventive healthcare practices. The robust support from governmental programs focused on biosecurity and animal welfare plays a crucial role in fostering this awareness, thus driving the growth of the India Porcine Vaccines Market Industry.

Rise in Pork Consumption

Pork has been emerging as a popular source of protein among Indian consumers, leading to increased pig farming. The Food and Agricultural Organization of the United Nations reported that per capita pork consumption in India has risen by approximately 10% over the last five years, indicating a strong consumer demand.

This escalating demand for pork necessitates enhanced vaccination protocols to ensure the health and productivity of pigs. Consequently, this trend is positively influencing the growth of the India Porcine Vaccines Market Industry, making vaccines an essential aspect of modern pig farming.

Government Initiatives and Support

The Indian government has implemented several initiatives to boost the livestock sector, focusing on improving animal health and productivity. For example, the National Livestock Mission aims to augment livestock production by promoting health care measures for various species, including pigs. These initiatives have significantly influenced farmers' access to vaccines, increasing the adoption rate of immunization practices among pig farmers. This strong governmental backing is critical in driving growth trends in the India Porcine Vaccines Market Industry, as it encourages farmers to invest in vaccination for better yields.

Advancements in Vaccine Technology

Innovations and advancements in vaccine technology are facilitating improved efficacy and efficiency in disease management for pig farming. Indian research institutions and universities are increasingly focusing on developing improved vaccines against endemic diseases affecting pigs. For instance, the Indian Council of Agricultural Research has reported progress in designing vaccines tailored to local strains of diseases.

Such advancements not only help in controlling disease outbreaks but also lead to decreased mortality rates among pigs, thereby encouraging farmers to prioritize vaccination. This development greatly benefits the animal health technology sector, such as the India Porcine Vaccines Market Industry, for technology is its backbone.

India Porcine Vaccines Market Segment Insights

Porcine Vaccines Market Type Insights

The India Porcine Vaccines Market exhibits a diverse range of types that play vital roles in safeguarding swine health and enhancing productivity. The major type categories include Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, and DNA vaccines. Inactivated vaccines are crucial for providing immunity without the risk of causing disease, making them a favored choice among veterinarians. These vaccines are essential in managing endemic diseases in pigs, thereby protecting the health of herds across India.

Live attenuated vaccines carry a live but weakened pathogen, which tends to yield strong immune responses, making them effective for preventive measures against various viral infections in swine. Toxoid vaccines offer significant benefits by targeting bacterial toxins rather than the bacteria themselves, thus proving vital in controlling diseases that produce harmful toxins.

Recombinant vaccines, on the other hand, utilize biotechnology to create vaccine components, fostering a more efficient immune response and broadening their application in enhancing swine health. Conjugate vaccines are noteworthy as they combine polysaccharides with proteins to enhance immunity, especially in cases where traditional vaccines may be less effective.

DNA vaccines are emerging as an innovative technology that leverages genetic material to provoke a protective immune response; their adaptability and potential for rapid development make them an important facet of future vaccine strategies. The overall segmentation of the India Porcine Vaccines Market reveals substantial opportunities for growth as swine farming continues to be a significant sector within the Indian agricultural landscape, where efficiency, health management, and disease prevention are crucial.

With advancements in veterinary biotechnology and a growing understanding of swine diseases, the market is likely to witness innovations and a shift towards more specialized vaccines tailored to meet the needs of Indian swine farmers. The increasing focus on livestock health and biosecurity practices drives the demand for these vaccines, as they play a fundamental role in improving the overall productivity and profitability of the pork industry. Understanding these dynamics within the Type segment is vital for stakeholders aiming to navigate the evolving landscape of the India Porcine Vaccines Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Porcine Vaccines Market Disease Indication Insights

The Disease Indication segment within the India Porcine Vaccines Market is a crucial aspect of the industry, focusing on various infectious diseases affecting swine populations. With the substantial increase in pig farming in India, there has been a growing emphasis on vaccines that target Porcine Epidemic Diarrhea (PED) and Porcine Reproductive and Respiratory Syndrome (PRRS), both of which have significant impacts on herd health and productivity.

The prevalence of Swine influenza remains a concern due to its potential to cause severe outbreaks, while Aujeszky's disease (AD) and Porcine Circovirus Associated Disease (PCVAD) also contribute significantly to economic losses among farmers. The increasing awareness of biosecurity measures, coupled with advancements in vaccine technology, is driving the demand for effective solutions in the Porcine market.

The market is witnessing a trend toward the development of multi-valent vaccines to combat various pathogens simultaneously, reflecting the evolving needs of the livestock sector. As India strives to enhance its livestock health standards and productivity, addressing these disease indications will play a vital role in securing the future of the country's pork industry.

Porcine Vaccines Market End-user Insights

The End-user segment of the India Porcine Vaccines Market plays a critical role in healthcare for swine, with Veterinary Hospitals and Hog Production Farms serving as key players in this landscape. Veterinary Hospitals are essential for administering vaccines and ensuring the health and productivity of pigs, acting as a primary point of contact for both preventive and treatment measures.

They contribute significantly to maintaining animal welfare and reducing disease outbreaks, which is crucial in a densely populated country like India, where the demand for pork is rising. On the other hand, Hog Production Farms dominate the industry, forming the backbone of pork supply and focusing on biosecurity and vaccination programs to enhance herd immunity and minimize losses due to diseases.

These farms are increasingly adopting advanced vaccination techniques and strategies to improve production efficiency and overall livestock health. The rising focus on antibiotic-free meat production is also driving the demand for effective vaccinal solutions in this segment. The interplay between these End-users significantly influences the market dynamics, highlighting the importance of both Veterinary Hospitals and Hog Production Farms in the overall landscape of the India Porcine Vaccines Market.

India Porcine Vaccines Market Key Players and Competitive Insights

The India Porcine Vaccines Market is characterized by a competitive landscape that includes both domestic and international players vying for significant market share. This market is driven by rising awareness about animal health, increased production of pork, and stringent regulations regarding animal vaccination to prevent diseases among porcine populations. The competitive dynamics are shaped by factors like technological advancements in vaccine development, pricing strategies, and strong distribution networks. Understanding the positioning of key players in this market is crucial for identifying trends and forecasting growth opportunities.

It is notable that market participants are increasingly focusing on research and development to introduce novel vaccine solutions that address emerging health challenges among pigs. Indian Immunologicals has established a strong foothold in the India Porcine Vaccines Market, primarily through its innovative vaccine formulations and commitment to quality. The company's strengths lie in its production capabilities and extensive distribution network across the country, enabling it to cater to various segments of the market effectively.

Indian Immunologicals has a reputation for producing high-quality porcine vaccines that meet both domestic and international standards, thereby gaining the trust of veterinarians and farmers alike. Furthermore, their customer-centric approach and focus on education about the importance of vaccination in swine health contribute to enhancing their market presence. The company’s ability to adapt to changing market needs further solidifies its competitive edge in the Indian landscape.

Ceva Animal Health is a prominent player in the India Porcine Vaccines Market, recognized for its comprehensive range of products and services tailored specifically to the needs of the swine industry. The company's key offerings include various vaccines that target prevalent diseases in pigs, supported by their strong research and development initiatives aimed at delivering effective health solutions.

Ceva's well-established market presence in India is bolstered by strategic partnerships and collaborations that enhance its distribution capabilities, ensuring that stakeholders have access to essential veterinary products. Their commitment to excellence is reflected in their continuous investment in innovation and technology, which positions Ceva as a leader in providing holistic animal health solutions. The company’s mergers and acquisitions have also expanded its product portfolio and geographical reach, allowing it to better serve the burgeoning porcine sector in India.

Key Companies in the India Porcine Vaccines Market Include

• Indian Immunologicals
• Ceva Animal Health
• Virbac
• Neogen Corporation
• Heska Corporation
• Zoetis
• Vetoquinol
• Petersime
• Biovet
• Elanco
• Zydus Cadila
• Merck Animal Health
• Hester Biosciences
• Boehringer Ingelheim
• Karnataka Veterinary Biologicals Corporation

India Porcine Vaccines Market Industry Developments

Recent developments in the India Porcine Vaccines Market have emphasized advancements in disease prevention and control, with several companies active in this space. Indian Immunologicals continues to innovate in porcine health solutions, while Ceva Animal Health and Virbac have introduced new vaccine formulations to combat viral diseases like Porcine Reproductive and Respiratory Syndrome (PRRS).

The market is experiencing significant growth due to increasing pig farming and heightened awareness of veterinary health. Notably, Zydus Cadila expanded its portfolio with the launch of new vaccines addressing specific pig diseases in July 2023, further enhancing its market presence.

Additionally, the regional demand has prompted companies like Zoetis and Elanco to invest in Research and Development for more effective vaccines. There have been no significant mergers or acquisitions reported in the past few months among key companies like Heska Corporation and Boehringer Ingelheim. The economic valuation of the porcine vaccine sector in India has been positively impacted, driven by a rising trend in livestock vaccination, reinforcing the importance of maintaining animal health standards in the face of growing meat consumption. The Indian government's initiatives to promote livestock health are also influencing market dynamics.

India Porcine Vaccines Market Segmentation Insights

Porcine Vaccines Market Type Outlook

• Inactivated vaccines
• Live attenuated vaccines
• Toxoid vaccines
• Recombinant vaccines
• Conjugate vaccines
• DNA vaccines

Porcine Vaccines Market Disease Indication Outlook

• PED (Porcine Epidemic Diarrhea)
• PRRS (Porcine Reproductive & Respiratory Syndrome)
• Swine influenza
• Aujeszky's disease (AD)
• Porcine Circovirus Associated Disease (PCVAD)
• Others

Porcine Vaccines Market End-user Outlook

• Veterinary Hospitals
• Hog Production Farm

 

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	89.5(USD Million)
MARKET SIZE 2024	96.0(USD Million)
MARKET SIZE 2035	213.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.514% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Indian Immunologicals, Ceva Animal Health, Virbac, Neogen Corporation, Heska Corporation, Zoetis, Vetoquinol, Petersime, Biovet, Elanco, Zydus Cadila, Merck Animal Health, Hester Biosciences, Boehringer Ingelheim, Karnataka Veterinary Biologicals Corporation
SEGMENTS COVERED	Type, Disease Indication, End-user
KEY MARKET OPPORTUNITIES	Increasing pig farming regulations, Growing demand for biosecurity measures, Rise in consumer health consciousness, Advancements in vaccine technology, Expansion of distribution networks
KEY MARKET DYNAMICS	increasing pork consumption, rise in swine diseases, government health initiatives, adoption of advanced vaccination technologies, growth of animal husbandry sector
COUNTRIES COVERED	India